Results 181 to 190 of about 320,642 (354)

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

EPIDEMIC ENCEPHALITIS [PDF]

BMJ, 1918
openaire   +2 more sources

Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia

, 2017
Kristina R. Patterson, Josep Dalmau, Eric Lancaster   +2 more
openalex   +2 more sources

Autoimmune Encephalitis, a Diagnostic and Therapeutic Challenge in the Intensive Care Unit.

, 2023
David Cordero, Ignacio Alberto, Mendez de Jesus, Saúl Trejo-Rosas, Yuridia Marisela Ortega Labra, Sonia Damián Flores, Juan José De La Rosa Vázquez, María Verónica Jacobo Castro, María de las Nieves Hernández Rodríguez, Alberto Santamaría Barragán, Francisco Omar Avendaño Hernández, Miriam Galicia de Jesús, Karen Quirino Garcia, Betzahida Meneses Cisneros, Magdalena Avalos Garcia, Adriana Desireé Velázquez Rivera   +15 more
openalex   +1 more source

Opsoclonus‐Myoclonus‐Ataxia Syndrome Associated with Coexisting Anti‐N‐Methyl‐D‐Aspartate Receptor and Glial Fibrillary Acidic Protein Antibodies

Movement Disorders Clinical Practice, EarlyView.
Eriko Igami, Yutaka Oji, Akihiro Yamaguchi, Shin‐ichi Ueno, Yuji Tomizawa, Taiji Tsunemi, Taku Hatano, Nobutaka Hattori   +7 more
wiley   +1 more source

A Transcriptomic Analysis of Cancer‐Stromal Interactome in Lung Cancer Xenograft Models

Cancer Science, EarlyView.
We conducted a comprehensive analysis of the lung cancer interactome to identify key ligand–receptor pairs involved in the aggressiveness of lung adenocarcinoma. Tumor necrosis factor superfamily member 12 and its receptor tumor necrosis factor receptor superfamily member 12A signaling axis may be potential candidates for therapeutic intervention for ...
Yuriko Takayama‐Isagawa, Daisuke Komura, Takayuki Isagawa, Yusuke Amano, Atsushi Kihara, Tamaki Miura, Taichiro Yoshimoto, Hiroyoshi Tsubochi, Kazutaka Fujita, Koichi Hagiwara, Makoto Maemondo, Tetsuo Ushiku, Shumpei Ishikawa, Noriyoshi Fukushima, Kentaro Inamura, Daisuke Matsubara, Toshiro Niki   +16 more
wiley   +1 more source

Clinical decision-making in relation to autoimmunity: insights from catatonia and autoimmune encephalitis. [PDF]

BJPsych Open
Erol A.
europepmc   +1 more source

A case of herpes simplex encephalitis with a favorable course observed following early treatment

S. Furuta, Arata Moriya, Koichiro Nakamura   +2 more
openalex   +2 more sources

IMpower010: 5‐Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB–IIIA Non‐Small Cell Lung Cancer

Cancer Science, EarlyView.
The global Phase 3 IMpower010 study (NCT02486718) evaluated atezolizumab versus best supportive care (BSC) after complete resection and adjuvant platinum‐based chemotherapy in patients with stage IB–IIIA non‐small cell lung cancer (NSCLC). Here, we report updated efficacy and safety results from the disease‐free survival (DFS) final and overall ...
Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe, Haruhiro Saito, Toyofumi F. Chen‐Yoshikawa, Yasushi Goto, Wataru Nishio, Shizuka Nakagawa, Morihiko Hayashi, Hirotsugu Kenmotsu   +9 more
wiley   +1 more source

Rasmussen Encephalitis [PDF]

The Neurohospitalist, 2016
G Abbas, Kharal, Sashank, Prasad
openaire   +2 more sources